Annual balance sheet for Pulmatrix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 53.8 | 35.6 | 19.2 | 9.52 | 4.09 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.067 | 1.3 | 0.928 | 0 | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 54.8 | 38.1 | 20.8 | 9.92 | 4.13 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.41 | 0.945 | 11.5 | 0 | — |
| Net Goodwill | |||||
| Other Long Term Assets | |||||
| Total Assets | 58.8 | 41 | 34 | 9.94 | 4.14 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.44 | 5.02 | 3.91 | 0.929 | 0.329 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11.4 | 9.84 | 16 | 0.996 | 0.329 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 47.4 | 31.1 | 18 | 8.95 | 3.81 |
| Total Liabilities & Shareholders' Equity | 58.8 | 41 | 34 | 9.94 | 4.14 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |